Literature DB >> 8891615

Naloxone sensitive orphanin FQ-induced analgesia in mice.

G C Rossi1, L Leventhal, G W Pasternak.   

Abstract

Orphanin FQ, also known as nociceptin, is a heptadecapeptide with very high affinity for a novel member of the cloned opioid receptor family which produces hyperalgesia in mice. In addition to hyperalgesia, which is observed soon after administration of orphanin FQ, we now describe a delayed analgesic response. Unlike orphanin FQ-induced hyperalgesia, orphanin FQ-induced analgesia is readily reversed by the opioid antagonist naloxone, implying an opioid mechanism of action. In view of the very poor affinity of orphanin FQ for all the known traditional opioid receptors and the low affinity of opioids for the 125I[Tyr14]orphanin FQ binding site, orphanin FQ-induced analgesia is probably mediated through a novel orphanin FQ receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891615     DOI: 10.1016/0014-2999(96)00578-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Mechanical stimulation activates small fiber mediated nociceptive responses in the nucleus gigantocellularis.

Authors:  Tomonari Nagata; Hidehiro Suzuki; Rihui Zhang; Makoto Ozaki; Yoriko Kawakami
Journal:  Exp Brain Res       Date:  2003-03-04       Impact factor: 1.972

2.  The central questions in pain perception may be peripheral.

Authors:  G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 3.  Orphan anxiety.

Authors:  J R Walker; G F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test.

Authors:  K Lutfy; N T Maidment
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

5.  Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.

Authors:  M A King; S Bradshaw; A H Chang; J E Pintar; G W Pasternak
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.

Authors:  F Jenck; J L Moreau; J R Martin; G J Kilpatrick; R K Reinscheid; F J Monsma; H P Nothacker; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding.

Authors:  Felix J Kim; Ivanka Kovalyshyn; Maxim Burgman; Claire Neilan; Chih-Cheng Chien; Gavril W Pasternak
Journal:  Mol Pharmacol       Date:  2010-01-20       Impact factor: 4.436

Review 9.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

10.  Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain.

Authors:  Camille Lagard; Lucie Chevillard; Karel Guillemyn; Patricia Risède; Jean-Louis Laplanche; Mariana Spetea; Steven Ballet; Bruno Mégarbane
Journal:  Pain       Date:  2017-03       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.